Despite the well-recognized increase in mortality and morbidity due to infections in the elderly, antibiotics may, in most cases, be used in a manner similar to that in younger patients. The decreased lean body weight and reduced renal function typical of elderly patients, however, require consideration of reduced doses and longer dosing intervals, especially for renally excreted antibiotics. Length of therapy should be conservative because underlying anatomic or functional predispositions to infections tend to complicate treatment. Oral antibiotics are equally well absorbed in the elderly and younger patients and may be used for the same indications as for younger patients. A notable, important difference in the choice of antibiotics for serious infections in older versus younger patients is that empirical therapy should be broader in spectrum for elderly patients, and especially for elderly long-term residents, since the variety of infecting bacteria tends to be greater and polymicrobial infections tend to be common.
Antibiotic Dosing in the Elderly: A Nonissue?
dosing in elderly patients should usually be based on lean body weight and calculated creatinine clearance, not on total body Many classes of drugs require special attention to dosing weight and serum creatinine level. The equations for calculatand dose intervals to avoid adverse events in elderly patients ing creatinine clearance, such as the traditionally employed that are rarely encountered in younger patients. Important exCockcroft-Gault calculation (creatinine clearance Å {(140 0 amples include cardiovascular agents such as antihypertensives age) 1 lean body weight} Ϭ (72 1 serum creatinine level), or antiarrhythmics, neurotropics such as sedatives and antipsyare inferior to measurements of serum antibiotic concentrations chotics, and anticonvulsants. Such drugs may or may not have or actual creatinine clearance but superior to estimation of different pharmacokinetic characteristics in elderly patients, serum creatinine alone [5] . but many of them have significantly different, clinically important pharmacodynamic properties in elderly patients. These Oral Antibiotic Use: A Nonissue changes in pharmacodynamic properties result from the increased prevalence of chronic diseases in the elderly, as well
The elderly absorb oral medications reliably. Although the as changes in functioning of cardiovascular, neurological, and peak antibiotic concentration may be blunted, probably from other organ systems that are thought to be caused by aging atrophy of gastrointestinal mucosa and decreased blood supply, itself; examples include the increased risk of upper gastrointestotal absorption, as measured by the area under the curve, is tinal hemorrhage with nonsteroidal antiinflammatory drugs or comparable to that in younger patients. Slowed or decreased serious arrhythmias from theophylline, risks in the elderly that excretion and metabolism of drugs, moreover, may result in are independent of doses.
higher serum trough concentrations and a longer duration of This is not the case with antibiotics. Antibiotic dosing is action of oral antibiotics. There are no indications that oral relatively unaffected by age-related changes, per se. If the basic therapy, when appropriately prescribed, is less effective in the rules for antibiotic dosing in all patients, regardless of age, are elderly or that parenteral therapy is safer when appropriate oral followed, taking into account the reduced total weight and therapy is available. usually reduced renal function of elderly patients, antibiotic doses and dose intervals will be appropriately chosen [1 -4] . The important corollary to this assumption is that antibiotic Antibiotic Choice: An Issue
One of the safest generalizations that may be drawn from decades of research and commentary on the treatment of infections in the elderly is that empirical therapy should be broader other antibiotic-resistant bacteria, perhaps independently of
• Oral therapy offers more convenience but reduced cost and toxicity other risk factors [10, 11] .
for older and younger patients alike.
• Aminoglycosides, amphotericin B, and vancomycin -antibiotics with Pneumonia. Clinical prevalence studies indicate that the a narrow therapeutic margin -should be avoided when possible.
causes of pneumonia in adults are changing, in part because the population contracting pneumonia now tends to be older than in the past-although other factors, e.g., selective survival of organisms in the presence of widespread antibiotic use, are unstreptococci, requiring consideration of vancomycin/gentamidoubtedly also responsible [12, 13] . Gram-negative, staphylocin for empirical therapy in order to provide coverage for staphcoccal, and polymicrobial pneumonias occur predominantly in ylococci, streptococci, and enterococci [38] . Because osteomythe elderly, and in the elderly nursing home patient in particular elitis in the elderly is more likely to be secondary to infected [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] . Although convincing confirmatory studies are lacking, pressure ulcers or to involve the lumbosacral vertebrae, gramthe seriously ill elderly with pneumonia should be treated with negative or polymicrobial infection involving anaerobic bactebroad-spectrum antibiotics that cover both gram-positive and ria and Enterobacteriaceae, in addition to staphylococcal infecgram-negative pathogens and, in some circumstances, atypical tion (as is typically encountered in younger patients), must be organisms [26, 27] . Previous empirical-treatment recommendaconsidered when empirical therapy is devised [39] . [40] yields a list of possible special concerns about antibiotic caused by E. coli is much less in older women [32, 33] . One use in the elderly, which are included in table 1. Regardless must assume that there is at least an equal chance that a UTI of method of dosing and the care with which serum levels are in an older woman is caused by a coliform other than E. coli, controlled, aminoglycoside nephrotoxicity and ototoxicity are such as a Proteus, Klebsiella, Enterobacter, Serratia, or Pseumore common. Cephalothin causes excess nephrotoxicity at domonas species. In addition, as many as one-third of older high doses, and erythromycin causes more ototoxicity if imwomen with UTI have more than one potential pathogen isopaired renal function is present. Higher doses of clarithromycin, lated in a urine culture [30, 31, 34] . This means that trimethosuch as those used for antimycobacterial therapy, are poorly prim-sulfamethoxazole, a previously dependable empirical tolerated by older patients. It is well recognized that the elderly choice for the treatment of UTI, may not have a sufficiently are at particular risk for isoniazid-related hepatotoxicity. Tribroad spectrum of antimicrobial activity for routine use and methoprim-sulfamethoxazole is more likely to cause neutrothat a fluoroquinolone that is concentrated in the urine is preferpenia in older persons. Blindness may occur from ordinary able [35 -37] . A similar situation probably pertains to older doses of ethambutol, and amikacin is preferable to streptomycin men, in whom fluoroquinolones have the additional advantage for treating elderly patients with tuberculosis who have renal of excellent penetration into prostatic tissues, but there are no or hearing impairment. Rimantadine has a wider therapeutic data to guide recommendations. margin than amantadine for elderly patients with or at risk of Miscellaneous infections. Gram-negative parotitis, sialadenicontracting influenza A. tis, and septic arthritis are usually infections of the elderly. Diarrheal illness in the elderly resident of a long-term-care facility is more likely to be bacterial than community-acquired.
Duration of Therapy: Probably an Issue
The elderly are at greater risk for Pseudomonas aeruginosa otitis externa and Listeria monocytogenes meningitis. The epiOverall, the mortality and morbidity associated with all serious infections tend to be higher in the elderly than in their demiology of endocarditis has changed over the past few decades, with a shift to older age groups, as rheumatic valvular younger counterparts, a generalization that holds true especially for residents of long-term-care facilities. Cutting corners with disease has become uncommon. The elderly are more likely to be infected with enterococci and nonenterococcal group D therapy in high-risk populations, prima facie, makes little sense.
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